Sano Genetics raises €10.3M Series A round
22 January 2024· London, United Kingdom· biotechnology, precision_medicine, genomics, b2b, software_hardware
The new funding will be used to meet the growing demand for its products, leverage AI further and expand its reach to more countries, becoming the ultimate precision trial platform, and to run similar programmes to lead the charge for predictive and preventive genetics.
Investors
LeadPlural
Also participating
SeedcampMMC VenturesEpisode 1 Ventures
About Sano Genetics
Stage
Series A
Headquarters
London, United Kingdom
Founded
2017
Team Size
51–200
Sectors
biotechnologyprecision_medicinegenomicsb2bsoftware_hardware